Publications

Search our bibliography using the filters on the right-hand side.

Displaying 151 through 200 of 223 publications.

Castellsague J, Riera-Guardia N, Calingaert B, Varas-Lorenzo C, Fourrier-Reglat A, Nicotra F, Sturkenboom M, Perez-Gutthann S. Individual NSAIDS and upper gastrointestinal complications: a systematic review and meta-analysis of observational studies (the SOS project). Drug Saf. 2012 Dec 1;35(12):1127-46.

Kaye JA, Castellsague J, Bui C, Calingaert B, McQuay LJ, Riera N, Saltus C, Quinlan S, Holick CN, Wahl PM, Suzart K, Rothman KJ, Wallander MA, Perez-Gutthann S. Risk of acute liver injury in a cohort of oral antimicrobial users. Poster presented at the 28th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 2012. Barcelona, Spain. [abstract] Pharmacoepidemiol Drug Saf. 2012 Aug 27; 21(Supp 3):92. doi: 10.1002/phar.1367

Riera-Guardia N, Saltus C, Bui C, Harris DH, Kaye JA, Tennis P, Castellsague J, Perez-Gutthann S. Back in Barcelona: the landscape of database research over the last decade. Poster presented at the 28th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 27, 2012. Barcelona. [abstract] Pharmacoepidemiol Drug Saf. 21(Suppl 3):S306-7.

Afonso A, Prieto-Alhambra D, Escudero Garcia A, Estany Gestal A, Martin-Merino E, Riera Guardia N, Lopez-Leon S, Perez-Gutthann S, Hernández-Díaz S. FarmacoEpiEnRed, a network for pharmacoepidemiology in Spain. Poster presented at the 28th International Conference on Pharmacoepidemiology; August 27, 2012. Barcelona, Spain. [abstract] Pharmacoepidemiol Drug Saf. 2012 Aug 27; 21(Suppl 3):193. doi: 10.1002/pds.3324

Pisa F, Castellsague J, Rosolen V, Riera-Guardia N, Giangreco M, Drigo D, Perez-Gutthann S. Impact of case validation on incidence rates of upper gastrointestinal complications. Poster presented at the 28th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 2012. Barcelona, Spain. [abstract] Pharmacoepidemiol Drug Saf. 2012 Aug; 21(Suppl 3):178. doi: 10.1002/pds.3324

Blackburn SCF, Arlett PR, Evans SJ, Perez-Gutthann S. New pharmacovigilance legislation: a call to arms to the pharmacoepidemiology community. Poster presented at the 28th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 2012. Barcelona, Spain. [abstract] Pharmacoepidemiol Drug Saf. 2012 Aug; 21(Suppl 3):339.

Sturkenboom M, Fourrier-Reglat A, Perez-Gutthann S, Garbe E, Nicotra F, Romio S. How to conduct collaborative studies in the EU? Lessons and results from the completed Safety of NSAIDs (SOS) Project. Pharmacoepidemiol Drug Saf. 2012;21(suppl 3):S38-9.

Varas-Lorenzo C, Riera-Guardia N, Calingaert B, Castellsague J, Pariente A, Scotti L, Sturkenboom M, Perez-Gutthann S. Stroke risk and NSAIDs: a systematic review of observational studies. Pharmacoepidemiol Drug Saf. 2011 Dec 1;20(12):1225-36.

Hollis K, Calingaert B, Gilligan TM, Sweeney C, Price M, Perez-Gutthann S, Andrews E. Quinolones REMS evaluation surveys. Poster presented at the 27th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 18, 2011. Chicago, IL.

Kaye JA, Castellsague J, Bui CL, Calingaert B, McQuay L, Riera Guardia N, Saltus CW, Quinlan S, Holick CN, Wahl PM, Rothman KJ, Wallander MA, Perez-Gutthann S. Case screening and validation in a population-based study of antimicrobial use and acute liver injury. Presented at the 27th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 14, 2011. Chicago, IL. [abstract] Pharmacoepidemiol Drug Saf. 2011 Aug 12; 20(S1):S5-6. doi: 10.1002/pds.2206

Castellsague J, Pisa F, Rosolen V, Riera-Guardia N, Giangreco M, Clagnan E, Tosolini F, Zanier L, Barbone F, Perez-Gutthann S. Use of nimesulide, other nsaids and the risk of upper gastrointestinal complications in Friuli Venezia Giulia, Italy. Analysis of cases with codes with high positive predictive value. Poster presented at the 27th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 2011. Chicago, IL. [abstract] Pharmacoepidemiol Drug Saf. 2011 Aug; 20(S1):S178.

Rubino A, Wallander MA, Callreus T, Saddier P, Ritchey ME, Perez-Gutthann S. Drug utilization studies and risk management plans: a missing link. Poster presented at the 27th International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 2011. Chicago, IL. [abstract] Pharmacoepidemiol Drug Saf. 2011 Aug 1; 20(Suppl. 1):S269.

Pisa F, Drigo D, Riera-Guardia N, Castellsague J, Rosolen V, Clagnan E, Tosolini F, Zanier L, Perez-Gutthann S, Barbone F. Validation of primary and secondary ICD-9-cm codes for upper gastrointestinal complications in Friuli Venezia Giulia, Italy. Poster presented at the 27th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 1, 2011. [abstract] Pharmacoepidemiol Drug Saf. 20(Suppl. 1):S172.

Perez-Gutthann S, de Abajo F, Garcia Rodriguez LA, Varas-Lorenzo C, Gutierrez L, Castellsague J. Pharmacoepidemiology: Epidemiology applied to pharmaceutical development, safety and risk. In: Hernández G, Moreno A, Zaragoza F, Porras A, editors. MEDIPHARM: Tratado de Medicina Farmacéutica. Madrid: Spain. Médica Panamericana; 2010.

Castellsague J, Holick CN, Hoffman CC, Gimeno V, Stang MR, Perez-Gutthann S. Risk of upper gastrointestinal complications associated with cyclooxygenase-2 selective and nonselective nonsteroidal antiinflammatory drugs. Pharmacotherapy. 2009 Dec;29(12):1397-407. doi: 10.1592/phco.29.12.1397

Miret M, Perez-Gutthann S, Gutierrez LP, Viglietta V, Musch B, Greenberg S. Evaluation of the long-term safety of Cladribine tablets: design of a prospective 8-year safety registry. Poster presented at the European Committee for Treatment and Research of Multiple Sclerosis (ECTRIMS); 2009. Dusseldorf, Germany. [abstract] Mult Scler. 2009 Sep 8; 15(Issue Suppl_9):S239. doi: 10.1177/1352458509106963

Riera-Guardia N, Hirst C, Castellsague J, Varas-Lorenzo C, Pariente A, Sturkenboom MCJM, Perez-Gutthann S. The SOS project: cardiovascular and gastrointestinal safety of NSAIDS. Preliminary results of a systematic review of epidemiological studies. Poster presented at the 25th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 2009. Providence, RI. [abstract] Pharmacoepidemiol Drug Saf. 2009 Aug 16; 18(Suppl 1):S207.

Perez-Gutthann S, Sturmer T, Platt R, Strom BL, Saddier P, Raine J. How should we plan and communicate interim results of pharmacoepidemiology studies? An ispe public policy forum. Poster presented at the 25th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 2009. Providence, RI. [abstract] Pharmacoepidemiol Drug Saf. 2009 Aug 16; 18(Suppl 1):S123-4.

Saddier P, Perez-Gutthann S, Stem-hagen A, Garg R, Blackburn S, Dal Pan G. Rmp, riskmap and rems: the challenges of epidemiology. Poster presented at the 25th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 2009. Providence, RI. [abstract] Pharmacoepidemiol Drug Saf. 2009 Aug 16; 18(Suppl 1):S203-4.

Varas-Lorenzo C, Castellsague J, Stang MR, Perez-Gutthann S, Aguado J, Rodriguez LA. The use of selective cycoxygenase-2 inhibitors and the risk of acute myocardial infarction in Saskatchewan, Canada. Pharmacoepidemiol Drug Saf. 2009;18(11):1016-25.

Varas-Lorenzo C, Castellsague J, Stang MR, Tomas L, Aguado J, Perez-Gutthann S. Positive predictive value of ICD-9 codes 410 and 411 in the identification of cases of acute coronary syndromes in the Saskatchewan Hospital automated database. Pharmacoepidemiol Drug Saf. 2008 Aug 1;17(8):842-52.

Varas-Lorenzo C, Rodriguez LA, Maguire A, Castellsague J, Perez-Gutthann S. Use of oral corticosteroids and the risk of acute myocardial infarction. Atherosclerosis. 2007 Jun;192(2):376-83.

Perez-Gutthann S, Cook S, Dai W, Hirst C, Andrews E. A call for international harmonization in therapeutic risk management. Pharmacoepidemiol Drug Saf. 2006 Dec 1;15(12):839-49.

Varas-Lorenzo C, McQuay L, Eaton S, Saez-Lloret I, Melero-Montes M, Miller D, Perez-Gutthann S. Characterization of US adult users of antihypertensive medications. Poster presented at the 22nd ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 28, 2006. Lisbon, Portugal.

Sanchez Matienzo D, Lanza LL, McQuay L, Gutierrez L, Arana Navarro A, Perez-Gutthann S. Descriptive study of users of depo-medroxyprogesterone acetate (DMPA) in the mhra gprd. Presented at the 22nd ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 27, 2006. Lisbon, Portugal.

Gimeno V, Bernat M, Stang MR, Aguado J, Castellsague J, Perez-Gutthann S. Validity of ICD9-codes for upper gastrointestinal bleeding in the Saskatchewan health databases. Poster presented at the 22nd International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 24, 2006. Lisbon, Portugal. [abstract] Pharmacoepidemiol Drug Saf. 2006 Aug; 15(S1):S231-2.

Hartford CG, Petchel KS, Mickail H, Perez-Gutthann S, McHale M, Grana JM, Marquez P. Pharmacovigilance during the pre-approval phases: an evolving pharmaceutical industry model in response to ICH E2E, CIOMS VI, FDA and EMEA/CHMP risk-management guidelines. Drug Saf. 2006 Aug 1;29(8):657-73. doi: 10.2165/00002018-200629080-00003

Varas-Lorenzo C, Maguire A, Castellsague J, Perez-Gutthann S. Quantitative assessment of the gastrointestinal and cardiovascular risk-benefit of celecoxib compared to individual NSAIDs at the population level. Poster presented at the 22nd ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 2006. Lisbon, Portugal. [abstract] Pharmacoepidemiol Drug Saf. 2006 Aug; 15(S1):S243.

Varas-Lorenzo C, Stang MR, Tomas L, Gimeno V, Castellsague J, Perez-Gutthann S. Positive predictive value of ICD-9 Code 411 in the identification of cases of acute coronary syndrome in the Saskatchewan Hospital Database. Poster presented at the 22nd ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 2006. Lisbon, Portugal. [abstract] Pharmacoepidemiol Drug Saf. 2006 Aug; 15(S1):S231.

Sanchez-Matienzo D, Arana A, Castellsague J, Perez-Gutthann S. Hepatic disorders in patients treated with COX-2 selective inhibitors or nonselective NSAIDs: a case/noncase analysis of spontaneous reports. Clin Ther. 2006 Aug 1;28(8):1123-32.

Perez-Gutthann S.Pérez Gutthann S, editors. Papers that shaped pharmacoepidemiology. Philadelphia: United States. Prous Science Barcelona; 2006.

Sakamoto C, Sugano K, Ota S, Sakaki N, Takahashi S, Yoshida Y, Tsukui T, Osawa H, Sakurai Y, Yoshino J, Mizokami Y, Mine T, Arakawa T, Kuwayama H, Saigenji K, Yakabi K, Chiba T, Shimosegawa T, Sheehan JE, Perez-Gutthann S, Yamaguchi T, Kaufman DW, Sato T, Kubota K, Terano A. Case-control study on the association of upper gastrointestinal bleeding and nonsteroidal anti-inflammatory drugs in Japan. Eur J Clin Pharmacol. 2006;62(9):765-72.

Sanchez-Matienzo D, Arana A, Castellsague J, Perez-Gutthann S. Hepatic disorders in users of NSAIDs, including COX-2 selective inhibitors. A case/non-case analysis of spontaneous reports. Clin Ther. 2006;28(8):1123-32.

Perez-Gutthann S. ISPE Commentary: twentieth annual conference on pharmacoepidemiology and therapeutic risk management. 2005.

Gimeno V, Castellsague J, Maguire A, Eaton SC, McQuay LJ, Zhou X, Perez-Gutthann S. Gastrointestinal and cardiovascular characterization of users of valdecoxib and other cox-2 specific inhibitors. Presented at the 20th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 22, 2004. Bordeaux, France. [abstract] Pharmacoepidemiol Drug Saf. 2004 Sep 23; 13(S1):S236.

Arana A, Arellano FM, Sánchez-Matienzo D, Perez-Gutthann S. Choosing the measure of relative proportional reporting in quantitative analyses of spontaneous reports. Presented at the 20th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 22, 2004. Bordeaux, France. [abstract] Pharmacoepidemiol Drug Saf. 2004 Sep 23; 13(Suppl 1):S324.

Maguire A, Arellano Felix M, Perez-Gutthann S, Arana A. Risk benefit modeling: the use of stochastic simulation for safety evaluations. Presented at the 20th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 22, 2004. Bordeaux, France. [abstract] Pharmacoepidemiol Drug Saf. 2004 Sep 23; 13(Suppl 1):S272.

Maguire A, Melero-Montes M, Saez-Lloret I, Varas-Lorenzo C, Perez-Gutthann S. Changes in hypokalemia and hyperkalemia between 1991 and 2000 in the US according to hypertensive status and treatment. Poster presented at the 20th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 2004. Bordeaux, France. [abstract] Pharmacoepidemiol Drug Saf. 2004 Sep; 13:S303.

Varas-Lorenzo C, García-Rodriguez LA, Perez-Gutthann S. Use of oral steroids and the risk of acute myocardial infarction in the UK. Poster presented at the 20th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 2004. Bordeaux, France. [abstract] Pharmacoepidemiol Drug Saf. 2004 Jul; 13(S1):S6.

Maguire A, Melero-Montes M, Saez-Lloret I, Varas-Lorenzo C, Perez-Gutthann S. Changes in hypokalemia and hyperkalemia prevalence between 1991 and 2000 in the US according to hypertensive status and treatment. Pharmacoepidemiol Drug Saf. 2004;13:S303.

Gimeno V, Castellsague J, Varas-Lorenzo C, Hopkins JS, Eaton SC, Perez-Gutthann S. Gastrointestinal and cardiovascular characterization of users of COX-2 specific inhibitors. Poster presented at the 1st International Conference on Therapeutic Risk Management & 19th ICPE International Conference on Pharmacoepidemiology; August 2003. Philadelphia, PA. [abstract] Pharmacoepidemiol Drug Saf. 2003 Aug; 12(S1):43.

Garcia-Rodriguez LA, Varas-Lorenzo C, Maguire A, Castellsague J, Gonzalez-Perez A, Perez-Gutthann S, Arellano A. Non-aspirin non-steroidal anti-inflammatory drugs (NANSAIDs) and the risk of acute myocardial infarction in the UK. Poster presented at the 1st International Conference on Therapeutic Risk Management & 19th ICPE International Conference on Pharmacoepidemiology; August 2003. Philadelphia, PA. [abstract] Pharmacoepidemiol Drug Saf. 2003 Aug; 12(S1):117.

Arana A, Castellsague J, Trave F, Perez-Gutthann S, Rothman KJ, Arellano FM. Early estimation of excess risk of serious cutaneous reactions for newly marketed drugs. Poster presented at the 1st International Conference on Therapeutic Risk Management & 19th ICPE International Conference on Pharmacoepidemiology; August 2003. Philadelphia, PA. [abstract] Pharmacoepidemiol Drug Saf. 2003 Aug; 12(S1):165.

Varas-Lorenzo C, Maguire A, Perez-Gutthann S. Serum potassium levels, hypertension and antihypertensive treatment in the US adult population: NHANES III (1988-1994). Poster presented at the 1st International Conference on Therapeutic Risk Management & 19th ICPE International Conference on Pharmacoepidemiology; August 2003. Philadelphia, PA. [abstract] Pharmacoepidemiol Drug Saf. 2003 Aug; 12(S1):54.

Tuells A, Arana A, Perez-Gutthann S, García-Rodríguez LA. El Proyecto BIFAP. Inv Clin Farm. 2003;0:25-6.

Castellsague J, García-Rodríguez LA, Duque A, Perez-Gutthann S. Risk of severe cutaneous disorders in users of oral antifungals. BMC Dermatology. 2002 Nov 28;2(14). doi: 10.1186/1471-5945-2-14

Castellsague J, Garcia-Rodriuez LA, Duque A, Perez S. Risk of serious skin disorders among users of oral antifungals: a population-based study. BMC Dermatology. 2002;2:14.

Arana A, Gutierrez L, Garcia-Rodriguez LA, Perez-Gutthann S. Antiepileptics and liver, testes, cervix uteri and vulvar cancer: a cohort study. Poster presented at the 17th International Conference on Pharmacoepidemiology; August 2001. Toronto, Canada. [abstract] Pharmacoepidemiol Drug Saf. 2001 Aug; 10(supp 1):128.

Varas-Lorenzo C, Perez-Gutthann S, Castellsague J, Gutierrez LP. Effects of transdermal hormone replacement therapy on cardiovascular outcomes: epidemiological evidence. In: Genazzani AR, editors. Hormone replacement therapy and cardiovascular disease. New York: United States. The Partenon Publishing Group Limited; 2001.